Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2012 1
2013 4
2014 3
2015 3
2016 1
2017 5
2018 2
2020 6
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Inside PD-1/PD-L1,2 with their inhibitors.
Boisgerault N, Bertrand P. Boisgerault N, et al. Eur J Med Chem. 2023 Aug 5;256:115465. doi: 10.1016/j.ejmech.2023.115465. Epub 2023 May 6. Eur J Med Chem. 2023. PMID: 37196547 Review.
Delivery of cancer therapies by synthetic and bio-inspired nanovectors.
Briolay T, Petithomme T, Fouet M, Nguyen-Pham N, Blanquart C, Boisgerault N. Briolay T, et al. Among authors: boisgerault n. Mol Cancer. 2021 Mar 24;20(1):55. doi: 10.1186/s12943-021-01346-2. Mol Cancer. 2021. PMID: 33761944 Free PMC article. Review.
Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells.
Grard M, Idjellidaine M, Arbabian A, Chatelain C, Berland L, Combredet C, Dutoit S, Deshayes S, Dehame V, Labarrière N, Fradin D, Boisgerault N, Blanquart C, Tangy F, Fonteneau JF. Grard M, et al. Among authors: boisgerault n. Cancer Immunol Immunother. 2023 Oct;72(10):3309-3322. doi: 10.1007/s00262-023-03486-4. Epub 2023 Jul 19. Cancer Immunol Immunother. 2023. PMID: 37466668
Oncolytic virotherapy for human malignant mesothelioma: recent advances.
Boisgerault N, Achard C, Delaunay T, Cellerin L, Tangy F, Grégoire M, Fonteneau JF. Boisgerault N, et al. Oncolytic Virother. 2015 Sep 10;4:133-40. doi: 10.2147/OV.S66091. eCollection 2015. Oncolytic Virother. 2015. PMID: 27512676 Free PMC article. Review.
Reply to: Oncolytic Viral Therapy for Malignant Pleural Mesothelioma.
Jean D, Delaunay T, Meiller C, Boisgerault N, Grard M, Caruso S, Blanquart C, Felley-Bosco E, Bennouna J, Tangy F, Grégoire M, Fonteneau JF. Jean D, et al. Among authors: boisgerault n. J Thorac Oncol. 2020 Jul;15(7):e113-e116. doi: 10.1016/j.jtho.2020.04.011. J Thorac Oncol. 2020. PMID: 32593448 Free article. No abstract available.
Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
Blondy T, d'Almeida SM, Briolay T, Tabiasco J, Meiller C, Chéné AL, Cellerin L, Deshayes S, Delneste Y, Fonteneau JF, Boisgerault N, Bennouna J, Grégoire M, Jean D, Blanquart C. Blondy T, et al. Among authors: boisgerault n. J Immunother Cancer. 2020 Jun;8(1):e000182. doi: 10.1136/jitc-2019-000182. J Immunother Cancer. 2020. PMID: 32581053 Free PMC article.
[The yellow fever vaccine as a new cancer treatment?].
Petithomme T, Grard M, Fonteneau JF, Boisgerault N. Petithomme T, et al. Among authors: boisgerault n. Med Sci (Paris). 2020 Dec;36(12):1216-1217. doi: 10.1051/medsci/2020236. Epub 2020 Dec 9. Med Sci (Paris). 2020. PMID: 33296641 Free article. French. No abstract available.
29 results